Monitor the upcoming earnings release on July 27 for actual Q2 results and any guidance updates. The stock may move based on the earnings surprise and forward outlook.
Price Chart
Executive Summary
OPKO Health announced it will report Q2 2026 financial results on July 27, 2026, with a conference call and webcast. The filing is a routine pre-announcement of an earnings date and contains no financial data or guidance. No actionable information is provided in this filing.
Key Facts
- OPKO will report Q2 2026 results on July 27, 2026
- Conference call and webcast at 4:30 p.m. ET on the same day
Financial Impact
No financial data reported in this filing
Risk Factors
- No actual financial data in this filing; earnings results are forthcoming
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3332451 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | 8-K | $1.65 $1.49 | ▼ −9.70% | ▼ −13.08% | $1.56 (−5.45%) |
Jul 23, 2026 10w ago | Press Release | $1.17 $1.46 | ▲ +24.79% | ▲ +21.48% | $1.56 (+33.33%) |
Jun 15, 2026 15w ago | Press Release | $1.40 $1.23 | ▼ −12.14% | ▼ −11.39% | $1.56 (+11.43%) |
May 15, 2026 20w ago | DEFA14A | $1.13 $1.39 | ▲ +23.01% | ▲ +21.43% | $1.56 (+38.05%) |
Apr 30, 2026 22w ago | Press Release | $1.13 $1.43 | ▲ +26.55% | ▲ +21.58% | $1.56 (+38.05%) |
Apr 22, 2026 23w ago | Press Release | $1.23 $1.15 | ▼ −6.50% | ▼ −9.67% | $1.56 (+26.83%) |
Apr 21, 2026 23w ago | Press Release | $1.23 $1.15 | ▼ −6.50% | ▼ −9.67% | $1.56 (+26.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access